Pacific Biosciences of California Inc expected to post a loss of 29 cents a share - Earnings Preview

Pacific Biosciences of California

13/02/2024 22:54

* Pacific Biosciences of California Inc  PACB.OQ 
 PACB.O  is
expected to show a rise in quarterly revenue when it reports 
results on February 15 for the period ending December 31 2023
    * The Menlo Park California-based  company is expected to
report a
110.2% increase in revenue to $57.486 million from $27.35
million a year ago, according to the mean estimate from 14
analysts, based on LSEG data.The company's guidance on January 8
2024, for the period ended December 31, was for revenue of
$58.400 million.
    * ​LSEG's mean analyst estimate for Pacific Biosciences of
California Inc is for a loss of 29 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Pacific
Biosciences of California Inc is $12.00​, above​ its last
closing price of $6.71. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.34       -0.33      -0.26     Beat    20.8
 Jun. 30 2023  -0.32       -0.32      -0.28     Beat    12.7
 Mar. 31 2023  -0.33       -0.33      -0.36     Missed  -8.3​
 Dec. 31 2022  -0.37       -0.36      -0.37     Missed  -2.4
 ​​Sep.        -0.33       -0.33      -0.34     Missed  -2.5
 30 2022                                                
 Jun. 30 2022  -0.32       -0.32      -0.32     Met     1​
 Mar. 31 2022  -0.31       -0.31      -0.37     Missed  -20
 Dec. 31 2021  -0.28       -0.28      -0.31     Missed  -9.4
 This summary was machine generated February 13 at 22:53 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)